Otro
Agents that inhibit histamine release: A review
Registro en:
Agents and Actions, v. 36, n. SUPPL., p. 87-95, 1992.
0065-4299
2-s2.0-0026587010
Autor
Gomes, J. C.
Resumen
It is well known that histamine is found in high concentration in mast cell granules(1). The histamine content of these granules may be released to the extracellular space if an appropriate stimulus is provided(2). Besides histamine, other preformed active substances like enzymes, chemotatic factors and proteoglycans, as well as newly generated mediators like eicosanoids, platelet activating factor and adenosine are released during the secretion process of mast cells(3). The activation of mast cell degranulation has been associated with a number of pathologic disorders, most frequently, diseases derived from the atopic state(4). It is now evident that mast cells are the primary effector cells in the early reaction in both allergic and non-allergic asthma(5,6), although some authors doubt that the late reaction of asthma is a mast cell dependent event(6). Other studies point towards basophils as cellular elements involved in the secondary phase of inflammation in allergic diseases(7). Secretion would depend on a histamine releasing factor, and on the presence of IgE on the basophil's surface(8). There is also evidence suggesting involvement of mast cells in some non-allergic inflammatory processes like arthritis(9). The pharmacological management of these diseases basically consists in the use of methylxantines, beta 2-adrenergic agonists, glucocorticoids, sodium cromoglycate-like drugs, anticholinergic and antihistaminic H 1 antagonists(10). Their therapeutic effects include bronchodilatation, receptor and physiological antagonism, prevention of inflammatory responses induced by secondary cells, and finally, inhibition of mast cell activation(11). This review is concerned with compounds having inhibitory action on mast cell activation, and their possible importance on the pathophysiology of mast cell-related diseases.
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
The possible involvement of hyperpolarizing mechanisms in histamine-induced relaxation of the rat portal vein
Rossignoli, Patrícia de S.; Rodrigues, Andréa D.; Tinti, Thaís; Pereira, Oduvaldo C. M.; Ellinger, Fred; Chies, Agnaldo B. -
The possible involvement of hyperpolarizing mechanisms in histamine-induced relaxation of the rat portal vein
Faculty of Medicine of Marília; Universidade Estadual Paulista (Unesp) (2008-11-07)The present study evaluated the effects of histamine 10 -2 M on longitudinal preparations of rat portal vein. It was observed that histamine 10 -2 M induced relaxation of rat portal vein preparations pre-contracted with ... -
Histamine H3 inverse agonist BF 2649 or antagonist with partial h4 agonist activity clobenpropit reduces amyloid beta peptide-induced brain pathology in alzheimer’s disease
Patnaik R.; Sharma A.; Skaper S.D.; Muresanu D.F.; Lafuente J.V.; Castellani R.J.; Nozari A.; Sharma H.S. (Humana Press Inc., 2018)